Topiramate Capsule, Extended Release
Product Images NDC 68462-372

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68462-372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Figure2.jpg (Figure2)

FDA Label Image

Lbl100mg30s.jpg (Lbl100mg30s)

FDA Label Image

Lbl150mg30s.jpg (Lbl150mg30s)

FDA Label Image

Lbl200mg30s.jpg (Lbl200mg30s)

FDA Label Image

Lbl25mg30.jpg (Lbl25mg30)

FDA Label Image

Lbl50mg30s.jpg (Lbl50mg30s)

FDA Label Image

Structure.jpg (Structure)

FDA Label Image

Company Logo

FDA Label Image

Figure3.jpg (Figure3)

This text seems to be describing dosages and results of a study involving the drug Topiramate, but there is not enough context to provide a more detailed description.*

FDA Label Image

Logo.jpg (Logo)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.